Drug intelligence / Profile preview

Refresh Contacts

Development stage: Unknown
Lead developer: Allergan
Modality: Small Molecules
Administration: Ophthalmic

Overview

Refresh Contacts is an over-the-counter (OTC) lubricant eye drop formulation developed by Allergan (now part of AbbVie) specifically for contact lens wearers. The active ingredient is carboxymethylcellulose sodium (CMC), a viscosity-enhancing polymer that acts as an artificial tear to provide relief from dryness, irritation, and discomfort associated with wearing contact lenses. It is designed to be applied directly to the eye while lenses are in place, helping to rewet the lenses and stabilize the tear film. The formulation often includes the Purite preservative system, which breaks down into natural tear components upon exposure to light, minimizing potential ocular surface irritation.

Brand names: Refresh Contacts
Other names: carboxymethylcellulose sodium ophthalmic solution

Beyond the preview

Go deeper on Refresh Contacts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Refresh Contacts.

Explore the full profile